urea has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 11 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In paroxysmal atrial fibrillation, landiolol hydrochloride reduced the heart rate from 111 +/- 20 to 90 +/- 10/min." | 5.09 | Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias. ( Atarashi, H; Endoh, Y; Hayakawa, H; Ino, T; Kuruma, A; Saitoh, H; Yashima, M, 2000) |
| "Landiolol was started at a dose of 1 μg/kg/min, after VT/VF was suppressed with electrical defibrillation." | 2.90 | Efficacy and Safety of the Ultra-Short-Acting β1-Selective Blocker Landiolol in Patients With Recurrent Hemodynamically Unstable Ventricular Tachyarrhymias - Outcomes of J-Land II Study. ( Daimon, T; Ikeda, T; Kinugawa, K; Nagai, R; Okamoto, H; Oki, K; Sakamoto, A; Shiga, T; Shimizu, W; Yamashita, T, 2019) |
| "Landiolol was administered intravenously with an initial dose of 2." | 2.75 | Effects of landiolol, an ultra-short-acting beta1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs. ( Abe, A; Hoshida, K; Ikeda, T; Ishiguro, H; Mera, H; Miwa, Y; Miyakoshi, M; Tsukada, T; Yanagisawa, R; Yoshino, H; Yusu, S, 2010) |
| "Lithium, a mood stabilizer used in the treatment of bipolar disorder is known for its anti-inflammatory properties with the discussion of its potential use in COVID-19 infection." | 1.72 | Lithium toxicity at therapeutic doses as a fallout of COVID-19 infection: a case series and possible mechanisms. ( Desai, G; Ganjekar, S; Malyam, V; Moirangthem, S; Murugesan, M; Pai, NM, 2022) |
| "But ventricular tachycardia is rare." | 1.34 | Incessant non-sustained ventricular tachycardia after stimulus of electroconvulsive therapy with atropine premedication? ( Kim, C; Kitamura, A; Nakanishi, K; Sakamoto, A; Sato, C; Yokozuka, M, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Pai, NM | 1 |
| Malyam, V | 1 |
| Murugesan, M | 1 |
| Ganjekar, S | 1 |
| Moirangthem, S | 1 |
| Desai, G | 1 |
| Nakagawa, R | 1 |
| Fujita, S | 1 |
| Shimao, A | 1 |
| Futatani, T | 1 |
| Hatasaki, K | 1 |
| Yamada, M | 1 |
| Takahashi, S | 1 |
| Yamashita, S | 1 |
| Tanaka, M | 1 |
| Ikeda, T | 2 |
| Shiga, T | 1 |
| Shimizu, W | 1 |
| Kinugawa, K | 1 |
| Sakamoto, A | 3 |
| Nagai, R | 1 |
| Daimon, T | 1 |
| Oki, K | 1 |
| Okamoto, H | 1 |
| Yamashita, T | 1 |
| Kanamori, K | 1 |
| Aoyagi, T | 1 |
| Mikamo, T | 1 |
| Tsutsui, K | 1 |
| Kunishima, T | 1 |
| Inaba, H | 1 |
| Hayami, N | 1 |
| Murakawa, Y | 1 |
| Mene-Afejuku, TO | 1 |
| Balogun, MO | 1 |
| Akintomide, AO | 1 |
| Adebayo, RA | 1 |
| Miwa, Y | 1 |
| Mera, H | 1 |
| Miyakoshi, M | 1 |
| Hoshida, K | 1 |
| Yanagisawa, R | 1 |
| Ishiguro, H | 1 |
| Tsukada, T | 1 |
| Abe, A | 1 |
| Yusu, S | 1 |
| Yoshino, H | 1 |
| Kim, C | 2 |
| Ogawa, R | 1 |
| Yokozuka, M | 1 |
| Sato, C | 1 |
| Nakanishi, K | 1 |
| Kitamura, A | 1 |
| Atarashi, H | 1 |
| Kuruma, A | 1 |
| Yashima, M | 1 |
| Saitoh, H | 1 |
| Ino, T | 1 |
| Endoh, Y | 1 |
| Hayakawa, H | 1 |
4 trials available for urea and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Efficacy and Safety of the Ultra-Short-Acting β1-Selective Blocker Landiolol in Patients With Recurrent Hemodynamically Unstable Ventricular Tachyarrhymias - Outcomes of J-Land II Study.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Asian People; Disease-Free Survival; Female; Humans; J | 2019 |
Comparison of arterial blood gases of laryngeal mask airway and bag-valve-mask ventilation in out-of-hospital cardiac arrests.
Topics: Aged; Blood Gas Analysis; Carbamide Peroxide; Carbon Dioxide; Cardiopulmonary Resuscitation; Drug Co | 2009 |
Effects of landiolol, an ultra-short-acting beta1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Drug Resistance; Femal | 2010 |
Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; D | 2000 |
7 other studies available for urea and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Lithium toxicity at therapeutic doses as a fallout of COVID-19 infection: a case series and possible mechanisms.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimanic Agents; Bipolar Disorder; COVID-19; Creatinine; F | 2022 |
Successful treatment of neonatal idiopathic ventricular tachycardia with landiolol hydrochloride.
Topics: Anti-Arrhythmia Agents; Female; Humans; Infant, Newborn; Morpholines; Remission Induction; Tachycard | 2019 |
Landiolol hydrochloride to successfully treat refractory ventricular arrhythmia during weaning from cardiopulmonary bypass.
Topics: Aged; Anti-Arrhythmia Agents; Cardiopulmonary Bypass; Electric Countershock; Female; Humans; Male; M | 2018 |
Successful Treatment of Refractory Electrical Storm With Landiolol After More Than 100 Electrical Defibrillations.
Topics: Adrenergic beta-Antagonists; Aged, 80 and over; Coronary Angiography; Electric Countershock; Electro | 2015 |
Prognostic indices among hypertensive heart failure patients in Nigeria: the roles of 24-hour Holter electrocardiography and 6-minute walk test.
Topics: Aged; Atrial Fibrillation; Biomarkers; Chi-Square Distribution; Echocardiography, Doppler; Electroca | 2017 |
Effect of landiolol on nonsustained ventricular tachycardia during electroconvulsive therapy.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Electroconvulsive Therapy; Humans; Male; | 2005 |
Incessant non-sustained ventricular tachycardia after stimulus of electroconvulsive therapy with atropine premedication?
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atropine; Depressive Disorder, Major; Electroca | 2007 |